LEUNG SANDRA (CIK 1199294) reported 17 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy BHC (6,845 shares), Buy BHC (5,946 shares), Buy BHC (4,586 shares), Buy BHC (3,673 shares), Buy BHC (30,149 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Bausch Health Companies Inc. (BHC) | Director | Buy | 6,845 | $33,746 |
| 2026-04-02 | Bausch Health Companies Inc. (BHC) | Director | Buy | 5,946 | $32,108 |
| 2026-01-02 | Bausch Health Companies Inc. (BHC) | Director | Buy | 4,586 | $0 |
| 2025-10-02 | Bausch Health Companies Inc. (BHC) | Director | Buy | 3,673 | $0 |
| 2025-07-29 | Bausch Health Companies Inc. (BHC) | Director | Buy | 30,149 | $0 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Buy | 5,858 | $0 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Sell | 404 | $0 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Sell | 2,790 | $176,077 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Buy | 5,349 | $0 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Sell | 933 | $0 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Sell | 2,259 | $142,565 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Buy | 5,415 | $0 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Sell | 923 | $0 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Sell | 2,298 | $145,027 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Buy | 32,096 | $0 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Sell | 11,837 | $0 |
| 2025-03-12 | BRISTOL MYERS SQUIBB CO (BMY) | EVP, General Counsel | Sell | 10,363 | $654,009 |
Source: SEC Form 4 filings · as of 2026-07-02